8 Feb 2018 16:48
Press Release
For immediate release
8 February 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Annual General Meeting results
The Board of MedicX Fund Limited is pleased to announce that at the Annual General Meeting of its Shareholders held earlier today, each of the resolutions was duly proposed and passed by the appropriate majority. The details of the number of votes recorded in respect of each resolution was as follows:
The following resolutions were passed as ordinary resolutions:
Resolution | In favour | % In favour | Against | % Against | Votes withheld |
1. To reappoint KPMG LLP as auditors | 182,400,582 | 99.99 | 12,034 | 0.01 | 15,750 |
2. To authorise the Directors to determine the auditors' remuneration | 182,428,366 | 100.00 | - | - | - |
3. To approve the Annual Report and Financial Statements | 182,384,573 | 99.98 | 43,792 | 0.02 | - |
4. To approve the dividend policy | 182,418,366 | 99.99 | 10,000 | 0.01 | - |
5. To approve the directors' remuneration report | 181,246,005 | 99.96 | 66,429 | 0.04 | 562 |
6. To re-appoint John Hearle as director | 182,316,619 | 99.95 | 93,963 | 0.05 | 17,784 |
7. To re-appoint Stephen Le Page as director | 181,181,854 | 99.94 | 113,358 | 0.06 | 17,784 |
8. To appoint Helen Mahy as director | 182,318,653 | 99.95 | 93,963 | 0.05 | 15,750 |
9. To appoint Laure Duhot as director | 181,195,888 | 99.94 | 101,358 | 0.06 | 15,750 |
The following resolutions were passed as special resolutions:
Resolution | In favour | % In favour | Against | % Against | Votes withheld |
10. Renewal of directors' authority to issue shares | 182,393,497 | 99.99 | 22,869 | 0.01 | 12,000 |
11. To authorise the Company to make market acquisitions of its ordinary shares (not exceeding 14.99 per cent. of its issued share capital, excluding treasury shares). | 182,357,187 | 99.96 | 71,179 | 0.04 | - |
12. (That subject to resolution 10) to authorise the directors to issue ordinary shares in the Company on a non pre-emptive basis | 182,402,655 | 99.99 | 9,000 | 0.01 | 16,711 |
Notes:
· A vote "withheld" is not a vote in law and is not calculated in the proportion of the votes "in favour" or "against" the resolution.
· The total number of voting rights at the proxy deadline was 428,833,331.
For further information please contact:
Octopus Healthcare Adviser Ltd +44 (0) 345 0404 5555
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity
Andrew Zychowski/Helen Goldsmith +44 (0) 20 7523 8000
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.
The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers
Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.
The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.